LEBEL FRANCOIS 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Feb 24, 2021
Insider Transaction Report
Form 4
LEBEL FRANCOIS
Chief Medical Officer
Transactions
- Award
Common Stock, $0.001 par value
2021-02-18+110,309→ 418,526 total - Award
Stock Option (Right to Buy)
2021-02-18+133,708→ 133,708 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (133,708 underlying) - Award
Stock Appreciation Right
2021-02-18+314,213→ 314,213 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (314,213 underlying)
Holdings
- 7,226(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F2]One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F3]One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.